rxstatShortages › Norepinephrine

Norepinephrine (Levophed) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Norepinephrine products are in shortage in Canada (1 of 5 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.

A medicine used to raise blood pressure in serious conditions such as shock.

Products affected
1 / 5
In shortage since
May 2, 2022
Reports on file
10
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
NOREPINEPHRINE BITARTRATE INJECTION USP
1MG · SOLUTION · GENERIC MEDICAL PARTNERS INC
DIN 02485680 · since May 2, 2022, no end estimate · Disruption of the manufacture of the drug.
Resolved
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
0.016MG · SOLUTION · BAXTER CORPORATION
DIN 02501430 · ended Jun 8, 2026 · Demand increase for the drug.
Resolved
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE INJECTION
0.032MG · SOLUTION · BAXTER CORPORATION
DIN 02501449 · ended Aug 29, 2024 · Delay in shipping of the drug.
Discontinued
LEVOPHED
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02241981
Resolved
LEVOPHED
1MG · SOLUTION · PFIZER CANADA ULC
DIN 02241981 · ended Jan 3, 2023 · Delay in shipping of the drug.
Resolved
NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00893285 · ended Oct 12, 2022 · Demand increase for the drug.
Avoided
LEVOPHED
1MG · SOLUTION · PFIZER CANADA INC
DIN 02241981 · ended Sep 19, 2018 · Disruption of the manufacture of the drug.
Resolved
LEVOPHED 1.0 MG/ML
1MG · SOLUTION · HOSPIRA HEALTHCARE CORPORATION
DIN 02241981 · ended Jun 6, 2018
Resolved
NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP
1MG · LIQUID · SANDOZ CANADA INCORPORATED
DIN 00893285 · ended Jan 16, 2018 · Demand increase for the drug.
Resolved
LEVOPHED 1.0 MG/ML
1MG · SOLUTION · HOSPIRA HEALTHCARE CORPORATION
DIN 02241981 · ended May 29, 2017 · Shortage of an active ingredient.

What's happening

Norepinephrine is currently affected by an active shortage report filed with Health Canada by GENERIC MEDICAL PARTNERS INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Norepinephrine is classified under “CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES” (ATC C01CA).

Recent changes

Common questions

What is Norepinephrine used for?

A medicine used to raise blood pressure in serious conditions such as shock.

When will Norepinephrine be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Norepinephrine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (cardiac stimulants excl. cardiac glycosides)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.